TY - JOUR
T1 - Accelerated theta burst stimulation for the treatment of depression
T2 - A randomised controlled trial
AU - Chen, Leo
AU - Thomas, Elizabeth H.X.
AU - Kaewpijit, Pakin
AU - Miljevic, Aleksandra
AU - Hughes, Rachel
AU - Hahn, Lisa
AU - Kato, Yuko
AU - Gill, Shane
AU - Clarke, Patrick
AU - Ng, Felicity
AU - Paterson, Tom
AU - Giam, Andrew
AU - Sarma, Shanthi
AU - Hoy, Kate E.
AU - Galletly, Cherrie
AU - Fitzgerald, Paul B.
N1 - Funding Information:
This work was supported by the Epworth Medical Foundation (Researcher Capacity Building Grant) and the Blue Sky Foundation . PBF is supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship ( 1078567 ). KEH is supported by a NHMRC Dementia Research Leader Fellowship ( 1135558 ). The authors would like to thank the patients, whose participation was essential for the successful completion of this study. We thank all of the nursing and administrative staff at the study centres for their invaluable assistance with participant coordination and treatment provision. We would also like to acknowledge the support of Epworth HealthCare , Ramsay Health Care (SA) and Queensland Health .
Funding Information:
This work was supported by the Epworth Medical Foundation (Researcher Capacity Building Grant) and the Blue Sky Foundation. PBF is supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (1078567). KEH is supported by a NHMRC Dementia Research Leader Fellowship (1135558). The authors would like to thank the patients, whose participation was essential for the successful completion of this study. We thank all of the nursing and administrative staff at the study centres for their invaluable assistance with participant coordination and treatment provision. We would also like to acknowledge the support of Epworth HealthCare, Ramsay Health Care (SA) and Queensland Health.
Publisher Copyright:
© 2021 The Authors
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Introduction: Theta burst pattern repetitive transcranial magnetic stimulation (TBS) is increasingly applied to treat depression. TBS's brevity is well-suited to application in accelerated schedules. Sizeable trials of accelerated TBS are lacking; and optimal TBS parameters such as stimulation intensity are not established. Methods: We conducted a three arm, single blind, randomised, controlled, multi-site trial comparing accelerated bilateral TBS applied at 80 % or 120 % of the resting motor threshold and left unilateral 10 Hz rTMS. 300 patients with treatment-resistant depression (TRD) were recruited. TBS arms applied 20 bilateral prefrontal TBS sessions over 10 days, while the rTMS arm applied 20 daily sessions of 10 Hz rTMS to the left prefrontal cortex over 4 weeks. Primary outcome was depression treatment response at week 4. Results: The overall treatment response rate was 43.7 % and the remission rate was 28.2 %. There were no significant differences for response (p = 0.180) or remission (p = 0.316) across the three groups. Response rates between accelerated bilateral TBS applied at sub- and supra-threshold intensities were not significantly different (p = 0.319). Linear mixed model analysis showed a significant effect of time (p < 0.01), but not rTMS type (p = 0.680). Conclusion: This is the largest accelerated bilateral TBS study to date and provides evidence that it is effective and safe in treating TRD. The accelerated application of TBS was not associated with more rapid antidepressant effects. Bilateral sequential TBS did not have superior antidepressant effect to unilateral 10 Hz rTMS. There was no significant difference in antidepressant efficacy between sub- and supra-threshold accelerated bilateral TBS.
AB - Introduction: Theta burst pattern repetitive transcranial magnetic stimulation (TBS) is increasingly applied to treat depression. TBS's brevity is well-suited to application in accelerated schedules. Sizeable trials of accelerated TBS are lacking; and optimal TBS parameters such as stimulation intensity are not established. Methods: We conducted a three arm, single blind, randomised, controlled, multi-site trial comparing accelerated bilateral TBS applied at 80 % or 120 % of the resting motor threshold and left unilateral 10 Hz rTMS. 300 patients with treatment-resistant depression (TRD) were recruited. TBS arms applied 20 bilateral prefrontal TBS sessions over 10 days, while the rTMS arm applied 20 daily sessions of 10 Hz rTMS to the left prefrontal cortex over 4 weeks. Primary outcome was depression treatment response at week 4. Results: The overall treatment response rate was 43.7 % and the remission rate was 28.2 %. There were no significant differences for response (p = 0.180) or remission (p = 0.316) across the three groups. Response rates between accelerated bilateral TBS applied at sub- and supra-threshold intensities were not significantly different (p = 0.319). Linear mixed model analysis showed a significant effect of time (p < 0.01), but not rTMS type (p = 0.680). Conclusion: This is the largest accelerated bilateral TBS study to date and provides evidence that it is effective and safe in treating TRD. The accelerated application of TBS was not associated with more rapid antidepressant effects. Bilateral sequential TBS did not have superior antidepressant effect to unilateral 10 Hz rTMS. There was no significant difference in antidepressant efficacy between sub- and supra-threshold accelerated bilateral TBS.
KW - Accelerated
KW - Depression
KW - Intensive
KW - Theta burst stimulation
KW - Transcranial magnetic stimulation
KW - Treatment-resistant depression
UR - http://www.scopus.com/inward/record.url?scp=85111656663&partnerID=8YFLogxK
U2 - 10.1016/j.brs.2021.07.018
DO - 10.1016/j.brs.2021.07.018
M3 - Article
C2 - 34332155
AN - SCOPUS:85111656663
SN - 1935-861X
VL - 14
SP - 1095
EP - 1105
JO - Brain Stimulation
JF - Brain Stimulation
IS - 5
ER -